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A novel  topical  combination  product  (BROADLINE®, Merial)  composed  of ﬁpronil,  (S)-
methoprene,  eprinomectin  and  praziquantel  was  evaluated  for safety  and  efﬁcacy  against
nematode  and  cestode  infections  in  domestic  cats.  The  study  comprised  a multi-centre,
positive  control,  blinded,  ﬁeld  study,  using  a randomized  block  design  based  on  order  of  pre-
sentation  for  allocation.  In  total  196  client-owned  cats,  conﬁrmed  as  positive  for naturally
acquired  infections  of  nematodes  and/or  cestodes  by  pre-treatment  faecal  examination,
were  studied  in seven  countries  in  Europe.  Pre-treatment  faecal  examination  revealed
the  presence  of Toxocara,  hookworm,  Capillaria  and/or  spirurid  nematode  infections  in
129, 73,  33  or  1 cat(s),  respectively;  infections  with  taeniid  and  Dipylidium  cestodes  were
demonstrated  in  39 and  17 cats, respectively.  Cats  were  allocated  randomly  to  one of two
treatments  in a ratio  of  2, topical  ﬁpronil  (8.3%,  w/v),  (S)-methoprene  (10%,  w/v),  epri-
nomectin  (0.4%,  w/v)  and  praziquantel  (8.3%,  w/v)  (BROADLINE®, Merial;  130 cats);  and  1,
topical  PROFENDER® Spot-On  (Bayer;  66  cats)  and  treated  once  on  Day  0. For  evaluation  of
l  samples  were  collected,  one  prior  to treatment  (Day  −4 ± 4  days)  andefﬁcacy,  two faeca
one at  the  end  of  the study  (Day  14  ± 5 days).  These  were  examined  for fecal  forms  of nema-
tode and  cestode  parasites.  For  evaluation  of  safety,  cats  were  examined  by  a veterinarian
before  treatment  and  at the  end of  the  study,  and  cat owners  recorded  the health  status  of
their cats daily  until  the end  of  the  study.
∗ Corresponding author. Tel.: +49 8032 70750; fax: +49 8032 707525.
E-mail address: steffen.rehbein@merial.com (S. Rehbein).
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For  cats treated  with  Broadline®, the  efﬁcacy  was  >99.9%,  100%,  and  99.6%  for Toxocara,
hookworms,  and  Capillaria,  respectively;  and the  efﬁcacy  was  >99.9%,  >99.9%,  and  98.5%,
respectively,  for  the  cats  treated  with  Profender® (p <  0.001  for all nematodes  and  both
treatments).  Efﬁcacy  was  100%  for  both  cestodes  for both  treatments  (p < 0.001).
No  treatment  related  adverse  experiences  were observed  throughout  the  study.  For  both
treatments,  every  cat  that  completed  the study  was given  a  safety  score  of ‘excellent’
for  both  local  and  systemic  evaluations.  The  topical  combination  product  of  ﬁpronil,  (S)-
methoprene,  eprinomectin  and  praziquantel  was  shown  to have  an  excellent  safety  proﬁle
and  demonstrated  high  levels  of  efﬁcacy  when  administered  once  as  topical  solution  to cats
infected  with  nematodes  and  cestodes  under  ﬁeld  conditions.
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. Introduction
Cats are hosts to a variety of internal parasites com-
rising protozoa, trematodes, cestodes, nematodes, and a
ew acanthocephalans. Some of these parasites, usually
epending on their abundance, may  impact the health
f cats and are known to cause problems ranging from
etarded growth or failure to thrive up to clinical intesti-
al disorders, such as diarrhoea or respiratory disease. In
ddition, cats, like other companion animals, represent
otential reservoirs, carriers and transmitters of several
iseases including zoonotic parasitic infections.
The most common helminth parasites of cats world-
ide are parasites of the gastrointestinal tract: ascarids
Toxocara cati and, with substantially lower preva-
ence and abundance, Toxascaris leonina), hookworms
mainly Ancylostoma tubaeforme and, depending on cli-
ate, other Ancylostoma species and occasionally Uncinaria
tenocephala), taeniid cestodes (predominately Taenia tae-
iaeformis but occasionally other Taenia species and on the
are occasion Echinococcus multilocularis in endemic areas)
nd tapeworms of the family Dipylidiidae (most commonly
ipylidium caninum but also species of Diplopylidium and
oyeuxiella). In addition, infections of cats by metastrongy-
oid and capillarid lungworms have been diagnosed with
ncreasing frequency in the recent past.
Parasites of domestic cats in Europe have been studied
xtensively in previous years and nematode and cestode
nfections have been shown to be a common occurrence.
owever, factors like category of cats (e.g., stray, feral, shel-
er, cattery, well-cared-for pet), habitat (urban or rural), or
eneral access to the outdoors, result in considerable vari-
bility in the prevalence of endoparasites (e.g., Borkovcová,
003; Coati et al., 2003; Omeragic´, 2003; Miró et al., 2004;
obben et al., 2004; Romaniuk et al., 2004; Ingstrup, 2008;
racenea et al., 2009; Keida¯ns et al., 2009; Overgaauw et al.,
009; Duarte et al., 2010; Ładczuk and Balicka-Ramisz,
010; Mircean et al., 2010; Traversa et al., 2010; Barutzki
nd Schaper, 2011; Claerebout et al., 2011; Knaus et al.,
011b; Becker et al., 2012; Mugnaini et al., 2012; Näreaho
t al., 2012; Zanzani et al., 2012; Capári et al., 2013; Riggio
t al., 2013).
Although intestinal helminth infections of cats may
ause limited clinical signs, they may  cause signiﬁcant
athology and the presence of these parasites may  be unac-
eptable to cat owners from aesthetic and hygienic points
f view as well as for veterinary and medical reasons. Thus,
ppropriate management practices for the control of felinelished  by  Elsevier  B.V.  This  is an  open  access  article  under  the  CC
D  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
helminth infections are required including the use of efﬁ-
cacious and safe antiparasitic drugs.
This paper reports the results of a multi-centre
ﬁeld study which was designed to evaluate the efﬁ-
cacy of a novel topical ﬁpronil, (S)-methoprene,
eprinomectin and praziquantel combination against
naturally acquired nematode and cestode infections and
the safety of the product at the recommended commercial
dose ranges in domestic cats.
2. Materials and methods
The study was designed in accordance with the
International Cooperation on Harmonisation of Techni-
cal Requirements for Registration of Veterinary Medicinal
Products – VICH GL7, “Efﬁcacy of Anthelmintics: Gen-
eral Requirements” (Vercruysse et al., 2001) and “Efﬁcacy
of Anthelmintics: Speciﬁc Recommendations for Felines”
VICH GL20 (Vercruysse et al., 2002), the “World Association
for the Advancement of Veterinary Parasitology (WAAVP)
guidelines for evaluating the efﬁcacy of anthelmintics for
dogs and cats” (Jacobs et al., 1994) and VICH GL9, entitled
Good Clinical Practice. An Informed Consent and Agreement
was obtained from the owners of the cats before enrolment.
All personnel involved in collecting efﬁcacy and safety
data, and the owners, were blinded to the treatment that
had been assigned to the animals.
2.1. Study animals
Client-owned cats of any breed and sex, with a mini-
mum  age of two  months and harbouring naturally acquired
nematode and/or cestode infections, as conﬁrmed by pre-
treatment fecal examination, were eligible to be included
in the study. The cats were in good condition and no suspi-
cion of parasitic infestation was  made before examination.
Fecal samples of 529 cats, from 284 owners, were col-
lected at eight sites in seven European countries (Albania,
57 cats; Austria, 53 cats; Bulgaria, 47 cats; Germany 1, 26
cats; Germany 2, 37 cats; Hungary, 120 cats; Latvia, 74
cats; Lithuania, 115 cats) and subjected to coproscopical
examination.
In total, 196 cats were conﬁrmed as positive for nat-
urally acquired infections of nematodes and/or cestodes
and were enrolled (Albania, 33 cats/21 owners; Austria, 15
cats/7 owners; Bulgaria, 34 cats/18 owners; Germany 1, 16
cats/8 owners; Germany 2, 22 cats/12 owners; Hungary, 37
cats/25 owners; Latvia, 16 cats/16 owners; Lithuania, 23
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cats/14 owners). These cats, 51 male, 20 male castrated, 98
female, 27 female spayed, were approximately two  months
to 13 years old and weighed 0.80–8.88 kg; 184 were com-
mon  European Shorthair or local mixed breed cats, and
12 were pedigree cats or pedigree cat crosses (British
Shorthair, European Longhair, Oriental Shorthair, Persian,
Siamese, Turkish Angora, PersianX, Turkish AngoraX). All
cats enrolled in the study were subjected to a physical
examination before treatment; three and four cats, respec-
tively, exhibited mild respiratory distress or had loose stool
at this time.
2.2. Faecal examination
To qualify animals for the study and for the evaluation of
efﬁcacy based on reduction of fecal nematode egg counts or
reduction of proportion of cats testing positive for cestode
infection following treatment, fresh faecal samples were
obtained before treatment and 14 ± 5 days post treatment
(enrolled animals only) for examination. The faecal samples
were examined, ﬁrst grossly for the presence of cestode
proglottids. Then, all samples were processed using modi-
ﬁed McMaster techniques to establish faecal nematode egg
counts. For ﬂoatation, zinc sulphate solution adjusted to a
speciﬁc gravity of 1.3 was used, but the amount of faeces
processed (2 g of faeces, six sites; 3 or 4 g of faeces, one
site each) and the sensitivity of counting techniques, var-
ied between sites (1 egg ≡ 20 eggs per g [EPG], one site; 1
egg ≡ 25 EPG, six sites; 1 egg ≡ 50 EPG, one site). Oocysts of
Isospora species, when present, were handled similarly, and
oocysts per g (OPG) counts were recorded. For taeniid and
Dipylidium cestodes, only the presence of either proglottids
or eggs was recorded. Identiﬁcation of parasites was based
on the distinct morphology of their faecal forms.
2.3. Evaluation of safety
The cats were examined physically by a veterinarian at
enrolment (before treatment) and at the end of the study.
Cat owners were required to report any adverse reactions
as soon as possible to the investigator and to record the
health status of their cats daily, until end of the study. At the
end of the study, the investigator evaluated the safety based
on the occurrence of any localized reactions at application
site and adverse events (Table 1).
2.4. Allocation of cats to treatment groups and treatment
administration
At each study site, replicates of three cats each were
formed, based on their order of presentation. Within repli-
cates, cats were allocated to one of two treatments accord-
ing to the allocation sequence in a ratio of 2, topical ﬁpronil
(8.3%, w/v), (S)-methoprene (10%, w/v), eprinomectin
(0.4%, w/v) and praziquantel (8.3%, w/v) (Broadline®,1
Merial; 130 cats): 1 topical emodepside/praziquantel
(PROFENDER® Spot-On, Bayer; 66 cats) and treated once
1 Broadline® is a trademark of Merial; all other marks are the property
of  their respective owners.itology 202 (2014) 10–17
on Day 0. For dose determination, cats were weighed on
the day of treatment administration (Day 0).
Broadline® was  available in the applicators of 0.3 mL  for
small cats (weighing ≥0.8–2.5 kg) and 0.9 mL  for large cats
(weighing >2.5–7.5 kg). Doses were administered topically
after parting the hair on the midline of the neck, between
the base of the skull and the shoulder blades, directly
onto the skin in one spot. Profender®, available in three
pipette sizes, was  administered according to the manufac-
turer’s instructions. Cats remained with their owners, in
their usual environments and received their usual food and
water.
2.5. Data analysis
Data from all study sites were combined for analysis,
including data from cats of complete and incomplete repli-
cates. Two  cats that did not complete the study (one cat
in each treatment group) were not included in any efﬁ-
cacy evaluation, and because they were not available for
the follow-up physical examination, they did not provide
safety information. Thus, data from 194 cats were retained
for analysis.
The primary efﬁcacy endpoint was  the fecal egg counts
for Capillaria, hookworm and Toxocara nematodes from
the individual cat. Percent efﬁcacy was  computed com-
paring the Day 14 (±5) sample with the Day −4 (±4)
sample for each treated group separately. Only cats that
had the parasite being evaluated in the Day −4 (±4) sam-
ple were included in the efﬁcacy evaluation and analysis.
For nematodes, the fecal egg counts for each animal were
transformed to the natural logarithm of (fecal egg count + 1)
for the calculation of geometric means. The percent efﬁ-
cacy of each treated group was  calculated using the formula
100 × [(B − E)/B], where B is the geometric mean of the
treated group on Day −4 (±4) and E is the geometric mean
of the treated group on Day 14 (±5). For cestodes, only
presence/absence information was  recorded. The percent
efﬁcacy of each treated group was calculated as the per-
cent of animals with cestodes present on Day −4 (±4) for
which no cestodes were present on Day 14 (±5).
Statistical analysis was conducted using SAS® version
9.1.3. To compare the faecal egg counts of the two mea-
surement days for the nematodes for each treatment group,
the Van Elteren rank test was used with sites treated
as blocks. The Freq Procedure was used employing the
Cochran-Mantel-Haenszel-2 option with score = modridit.
For cestodes, because animals were included only if they
were positive on Day −4 (±4), comparing the two mea-
surement days equated to testing whether the population
proportion of animals testing positive on Day 14 (±5) was
less than 1.0. The data were pooled over the sites and it was
assumed that the proportion positive for each cestode on
Day 14 (±5) could be approximated by a normal probability
distribution. The Freq Procedure was used to compare base-
line with study end, employing the Binomial option with
tables setting the hypothesized value of the proportion to
P = 0.99.
Non-inferiority analysis was  used to compare the novel
combination product with the reference product: the null
hypothesis that Broadline was  worse than Profender versus
S. Rehbein et al. / Veterinary Parasitology 202 (2014) 10–17 13
Table  1
Categories for assessment of local and systemic safety.
Score Safety Guidance criteria
Local
safety
0 ‘Excellent’ Nothing observed/physiologic
1 ‘Acceptable’ Mild localized reaction, e.g., short lasting mild reaction of skin at application site
2  ‘Poor’ Serious or unacceptable localized reaction observed, e.g., longer lasting reaction of skin, intense scratching
at  application site
Systemic
safety
0  ‘Excellent’ No adverse event noted
1  ‘Acceptable’ Mild adverse events observed, judged acceptable
2  ‘Poor’ Serious or unacceptable adverse event(s) related to treatment observed
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fhe alternative hypothesis that Broadline was equal to
r better than Profender was tested. For nematodes, the
xpected fecal egg count per gram for each treatment group
t Day 14 (±5) for each classiﬁcation of nematode was com-
ared using the mixed procedure in SAS version 9.1.3. The
on-inferiority threshold was 2 eggs per gram. The log-
ecal egg counts were the dependent variable, Treatment
as the ﬁxed effect, and Site was the random effect. A
wo-sided 95% conﬁdence interval was computed on the
roadlineTM–Profender® difference. If the upper limit (the
ne-sided 97.5% conﬁdence limit) was at or below 0.69
log (2)), then the null hypothesis was rejected and the
ata supported that BroadlineTM was equal to or better
han Profender®. The proportion of cats that had cestodes
resent on Day 14 (±5) of the two groups was compared
or each type of cestode represented. The data were pooled
ver the sites, and the two-sided 95% conﬁdence interval of
he difference between the two Treatments was computed,
ssuming that each proportion could be approximated
y a normal probability distribution. The non-inferiority
hreshold was 0.15 (15%). If the upper limit of the conﬁ-
ence interval on the difference in the proportions was at
r below 0.15, then the null hypothesis was rejected and
he data supported that the two products were equiva-
ent. To compute the upper conﬁdence limit, the average of
he proportions from the two treatment groups was used
o estimate the variance for the difference between the
reatment groups. When the observed proportions for both
able 2
verall prevalence and number of parasite stages in the faeces of 529 cats from Alb
or  enrolment in the study, as determined by gross faecal examination for expelle
Parasite stage Prevalence 
Number of cats positive at Day
Toxocara eggs 129 
Hookworm eggs 73 
Capillaria eggs 35 
Spirurid eggs 1 
Taeniid  eggs/proglottids 39 
Dipylidium eggs/proglottids 17 
Isospora oocysts 27 
a EPG = eggs per gram of feces.
b For Capillaria in two cats in Bulgaria only ‘presence’ was  recorded instead of f
c NR = not recorded.
d OPG = oocysts per gram of feces.group were 0.0, the averaged proportion was  estimated
by Pave = 1/(2(n1 + n2)), where n1 and n2 are the number
of cats treated with BroadlineTM and Profender®, respec-
tively, that had that particular parasite on Day −4 (±4).
3. Results
3.1. Prevalence of endoparasite infections in the cats
examined for enrolment
Of the 529 cats that were examined for potential
enrolment in the study, 207 (39.1%) had evidence of
infection with endoparasites (nematodes, cestodes and/or
protozoans), as determined by standard coproscopic exam-
ination (gross examination plus examination by modiﬁed
McMaster techniques). Total prevalence and count of faecal
forms of endoparasites detected, if applicable, are given in
Table 2. Identiﬁcation of the faecal forms revealed eggs of
nematodes (Toxocara, hookworm, Capillaria and spirurid),
Dipylidium and taeniid cestode proglottids and/or eggs,
and oocysts of protozoans of the genus Isospora. Over-
all, Toxocara was the most prevalent parasite followed by
hookworm. Of the cats, 21.9% showed infection with a sin-
gle parasite and 17.2% with multiple parasites (up to four
parasites concurrently were observed) (Table 3). Table 4
summarizes the percent prevalence of endoparasite infec-
tions in the cats examined in the individual countries.
ania, Austria, Bulgaria, Germany, Hungary, Latvia, and Lithuania examined
d parasite stages and modiﬁed McMaster techniques.
Range of counts
 −4 (±4) %
24.4 25–13,700 EPGa
13.8 25–4900 EPG
6.6 20–1375 EPGb
0.2 (25 EPG)
7.4 NRc
3.2 NR
5.1 20–26,400 OPGd
ecal egg count.
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Table 3
Occurrence of single- and mixed endoparasite infections of 529 cats from
Albania, Austria, Bulgaria, Germany, Hungary, Latvia, and Lithuania exam-
ined for enrolment in the study, as determined by gross faecal examination
for expelled parasite stages and modiﬁed McMaster techniques.
Prevalence: total (%)
Single endoparasite infections 116 (21.9)
Toxocara 59 (11.1)
Hookworm 20 (3.8)
Capillaria 4 (0.8)
Taeniid 18 (3.4)
Dipylidium 4 (0.8)
Isospora 11 (2.1)
Mixed endoparasite infections 91 (17.2)
Capillaria + hookworm 14 (2.6)
Capillaria + Toxocara 3 (0.6)
Hookworm + Toxocara 17 (3.2)
Hookworm + Dipylidium 1 (0.2)
Hookworm + taeniid 1 (0.2)
Hookworm + Isospora 1 (0.2)
Hookworm + spirurid 1 (0.2)
Toxocara + Dipylidium 9 (1.7)
Toxocara + taeniid 13 (2.5)
Toxocara + Isospora 11 (2.1)
Taeniid + Isospora 1 (0.2)
Capillaria + hookworm + Toxocara 10 (1.9)
Capillaria + hookworm + Dipylidium 1 (0.2)
Hookworm + Toxocara + Dipylidium 1 (0.2)
Hookworm + Toxocara + taeniid 1 (0.2)
Hookworm + taeniid + Isospora 1 (0.2)
Toxocara + taeniid + Isospora 1 (0.2)
Capillaria + hookworm + Toxocara + taeniid 2 (0.4)
Capillaria + hookworm + Toxocara + Dipylidium 1 (0.2)
It is noteworthy that Capillaria eggs were detectedHookworm + Toxocara + taeniid + Isospora 1 (0.2)
3.2. Evaluation of efﬁcacy
Of the 196 (37.1%) cats which had evidence of infection
with nematodes and/or cestodes and were enrolled in the
study, allocated and treated once on Day 0, two cats did not
complete the study (one cat harbouring Capillaria and Tox-
ocara infections was reported as lost by the owner and one
other cat harbouring Toxocara was struck by a car and died).
Thus, analysis was based on data from 194 cats of which
127, 73 and 32 cats had evidence of Toxocara, hookworm,
and Capillaria nematodes, respectively. Only ‘presence’ of
Capillaria was recorded in two cats from Bulgaria instead
of faecal egg count, resulting in 30 cats included in the efﬁ-
cacy evaluation for Capillaria). Thirty-nine and 17 cats had
evidence of taeniid and Dipylidium cestodes, respectively,
and were included in the efﬁcacy evaluation.
Table 4
Percent prevalence of endoparasite infections in the cats examined in Albania, A
by  by gross faecal examination for expelled parasite stages and modiﬁed McMast
Parasite Albania Austria Bulga
(n  = 57) (n = 53) (n = 4
Capillaria 31.6 3.8 4.3 
Hookworm 54.4 7.5 21.3 
Spirurid 1.8 0 0 
Toxocara 19.3 24.5 53.2 
Dipylidium 5.3 0 27.7 
Taeniid 1.8 7.5 0 
Isospora 10.5 1.9 0 
Overall nematode and/or cestode 57.9 28.3 72.3 itology 202 (2014) 10–17
For cats treated with topical ﬁpronil, (S)-methoprene,
eprinomectin and praziquantel, the efﬁcacy was >99.9%,
100%, and 99.6% for Toxocara, hookworms, and Capillaria,
respectively; and the efﬁcacy was >99.9%, >99.9%, and
98.5%, respectively, for the cats treated with topical emod-
epside/praziquantel (P < 0.001 for all nematodes and both
treatments) (Table 5). Efﬁcacy was  100% for both cestodes
in both treatment groups (P < 0.001) (Table 6).
For all three nematodes and taeniid cestodes, the
null hypothesis was rejected, and the data supported
that Broadline was  equal to or better than Profender at
the (one-sided) 2.5% signiﬁcance level; however, because
insufﬁcient numbers of animals were infected with Dipy-
lidium,  the upper conﬁdence limit was  not less than the
non-inferiority threshold in spite of the two treatments
having identical 100% efﬁcacies (Tables 5 and 6).
3.3. Evaluation of safety
No adverse experiences related to the treatments were
observed throughout the study. Every cat in each treatment
group that completed the study was  given a safety score of 0
(‘Excellent Safety’) for both local and systemic evaluations.
4. Discussion
By examination of faecal samples of domestic cats from
seven countries in Europe using conventional coproscopic
techniques, it was determined that almost 40% of the
cats had evidence of endoparasite infections. The spec-
trum of parasites identiﬁed in terms of their faecal forms
comprised mainly parasites of the gastrointestinal tract:
coccidians of the genus Isospora, ascarids of the genus
Toxocara, hookworms (Ancylostomatidae), tapeworms of
the genus Dipylidium and taeniid cestodes. All these para-
sites are common parasites of cats worldwide, and their
occurrence in cats has been documented in the respec-
tive countries previously (e.g., Mustejkajte et al., 1961;
Genov, 1971; Stoichev et al., 1982; Supperer and Hinaidy,
1986; Fok et al., 1988; Raschka et al., 1994; Schuster et al.,
1997; Takács and Takács, 2002; Keida¯ns et al., 2008, 2009;
Barutzki and Schaper, 2011; Knaus et al., 2011a,b; Becker
et al., 2012; Capári et al., 2013).in the faeces of cats from all seven countries with an
overall prevalence of 6.6%. Capillaria eggs (Fig. 1) found
in the faeces of cats are unlikely to be derived from
ustria, Bulgaria, Germany, Hungary, Latvia, and Lithuania, as determined
er techniques.
ria Germany Hungary Latvia Lithuania
7) (n = 63) (n = 120) (n = 74) (n = 115)
1.6 5.0 4.1 2.6
0 16.7 8.1 1.7
0 0 0 0
38.1 22.5 18.9 13.0
1.6 0 0 0
39.7 6.0 0 3.6
0 3.3 0 7.8
60.3 30.8 21.6 20.0
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Table  5
Faecal nematode egg counts before (Day −4 ± 4) and after (Day 14 ± 5) treatment, percentage efﬁcacy and results of data analysis.
Nematode Treatmenta Nb Analysis of fecal egg counts (Van Elteren rank test) Non-inferiority analysis
Geometric mean (EPG)c % Efﬁcacyd P-valuee Upper 97.5% CIf Thresholdg
Day −4 (±4) Day 14 (±5)
Capillariah 1 19i 110.6 0.5 99.6 <0.001 0.63 0.69
2  13 65.1 1.0 98.5 <0.001 NAj NA
Hookworm 1  42 258.7 0.0 100 <0.001 0.07 0.69
2  31 410.0 0.1 >99.9 <0.001 NA NA
Toxocara 1  86 483.7 0.1 >99.9 <0.001 0.21 0.69
2  41 439.1 0.3 >99.9 <0.001 NA NA
a Treatment 1 = Broadline, Treatment 2 = Profender.
b Number of cats analysed per Treatment.
c Geometric mean fecal egg count, EPG = eggs per gram of faeces, pre-treatment (Day −4 ± 4) and post treatment (Day 14 ± 5).
d Percent efﬁcacy = 100 × [(B − E)/B], where B and E are the geometric mean fecal egg counts at Day −4 (±4) and at Day 14 (±5), respectively.
e (Two-sided) probability comparing Day 14 (±5) with Day −4 (±4) for each Treatment within each nematode.
f The upper 97.5% conﬁdence limit on the difference of Treatment 1 −Treatment 2 was computed on the log-counts in the mixed procedure. If the upper
limit  is less than the threshold, then for that nematode, Treatment 1 was  signiﬁcantly not inferior to Treatment 2 at the 5% signiﬁcance level, and under
the  hypothesis that the two Treatments had comparable fecal egg counts if the ratio of the means is less than 2.
g Threshold = logarithm of 2.
h For Capillaria in two cats (Bulgaria) allocated in Treatment 1 only ‘presence’ was recorded instead of fecal egg count. Thus, they were not included in
the  efﬁcacy evaluation for Capillaria (although they were considered for inclusion in the analyses of the other nematodes). However, because both were
a  cats we
non-infe
b
i
h
t
m
d
o
2
f
a
(
v
c
e
c
T
P
r
a
ossigned ‘0’ (no Capillaria present), the ‘0’ was equated to 0 EPG, and both
i Nineteen cats were included in percent efﬁcacy evaluation, 21 in the 
j NA = not applicable.
ladder worms but may  originate from capillarids residing
n the gastrointestinal tract or the lungs, or the eggs may
ave passed through the alimentary tract following inges-
ion of parasitized prey. Although there was no detailed
icroscopic examination of the morphology of the eggs to
istinguish the eggs of Capillaria aerophila from those of
ther capillarids (cf. Bowman et al., 2002; Traversa et al.,
011), the frequent detection of Capillaria eggs in the cats’
aeces may  support the hypothesis that the lungworm C.
erophila is spreading in Europe in both dogs and cats
Traversa et al., 2009, 2010; Di Cesare et al., 2011). Pre-
iously, ﬁnding capillarids in the stomach or intestine of
ats was relatively rare (Thienpont et al., 1981; Raschka
t al., 1994). The spirurid eggs found in the faeces of one
at from Albania may  have originated from parasites of the
able 6
roportions of cestode-positive cats before (Day −4 ± 4) and after (Day 14 ± 5) tre
Cestode Treatmenta Analysis of proportion of cestode-positive 
Number of catsb %
Day −4 (±4) Day 14 (±5)
Dipylidium 1 10 0 1
2  7 0 1
Taeniid 1  26 0 1
2  13 0 1
a Treatment 1 = Broadline, treatment 2 = Profender.
b Number of cats that had evidence of the indicated cestode pre-treatment (Da
c Percent efﬁcacy = 100 × [(B − E)/B], where B and E are the numbers of cats that
espectively.
d Probability value testing that the probability was 1 of ﬁnding evidence of the
e Upper conﬁdence interval = (P1 − P2) + 1.960
√
{1/n1 + 1/n2)Pave(1 − Pave)}, 
t  Day 14 (±5) for treatments 1 and 2, respectively, 1.960 is the 97.5th ordinate as
f  cats that had the indicated genera at Day −4 (±4), and Pave is the arithmetic av
f Threshold = 0.15.
g NA = not applicable.re included in the non-inferiority analysis for Capillaria.
riority analysis (cf. Footnote h).
gastrointestinal tract (for instance, anecdotal records of
Physaloptera species in single cats from Hungary (Kávai,
1977) and Greece (Haralampides, 1978) or simply may
have passed through the alimentary tract following inges-
tion of parasitized prey.
The overall rate of nematode and/or cestode infection
of the cats varied between sites. However, this variability
probably reﬂects the habitats from where the cats origi-
nated. For example, cats examined in Bulgaria, Germany
and Hungary originated nearly exclusively from rural areas
and those screened in Albania from suburban areas, while
cats examined in Austria, Latvia and Lithuania predomi-
nately came from urban situations.
The results of this multi-centre study showed the
new topical combination of ﬁpronil, (S)-methoprene,
atment, percentage efﬁcacy and results of data analysis.
cats Non-inferiority analysis
 Efﬁcacyc P-valued Upper 97.5% CIe Thresholdf
00 <0.001 0.16 0.15
00 <0.001 NAg NA
00 <0.001 0.07 0.15
00 <0.001 NA NA
y −4 ± 4) and post treatment (Day 14 ± 5), respectively.
 had evidence of the indicated cestode at Day −4 (±4) and at Day 14 (±5),
 cestodes at Day 14 (±5) given that it was present at Day −4 (±4) was 1.
where P1 and P2 are the proportion of evidence of the indicated cestode
sociated with the standard normal distribution, n1 and n2 are the number
erage of P1 and P2. When P1 = P2 = 0, then Pave = 1/(2(n1 + n2)).
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eprinomectin and praziquantel is highly efﬁcacious in the
treatment of naturally acquired nematode and cestode
infections under ﬁeld conditions and thus conﬁrm the
results of the range of dose conﬁrmation studies con-
ducted under laboratory conditions using both induced and
naturally infected cats (Knaus et al., 2014a,b,c,d; Prullage
et al., 2014; Tielemans et al., 2014a). The cats included
in the study represented a wide range of geographic ori-
gins, ages, body weights, breeds, and spectrum of parasite
infections. The nematode and cestode parasites that were
treated successfully with the novel combination product
are important causes of health issues in cats and may  have
zoonotic potential (Sˇteˇrba and Barusˇ, 1976; Ekanayake
et al., 1999; Lalosˇevic´ et al., 2008; Bowman et al., 2010;
Lee et al., 2010; Lloyd, 2011). Almost 50% of the parasite-
positive cats included in the study harboured infections of
at least two helminth parasites, and approximately 17% had
evidence of concurrent nematode and cestode parasites.
These ﬁndings are indicative of the common occurrence of
multiparasitism in cats and thus favour the use of products
providing both broad-spectrum nematocidal and cestoci-
dal activity.
The novel topical combination would appear to offer
a highly effective product for convenient administration
in one spot to treat the most common parasitic infec-
tions of cats as its spectrum of activity covers not only
adult and developing nematodes and cestodes but also
ectoparasites, i.e. ﬂeas and ticks (Baker et al., 2014;
Tielemans et al., 2014b). The results demonstrate that
ﬁpronil, (S)-methoprene, eprinomectin and praziquantel,
when administered once as topical solution to cats infected
with nematodes and/or cestodes, is highly efﬁcacious
against a broad range of important nematode and cestode
parasites and demonstrates excellent safety under ﬁeld
conditions.
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